$EHTH
eHealth, Inc. Stock $ehth

$ehth Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000133349315000044 Filed on May 08, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$61.29M	$50.94M
YoY Change	20.31%	17.9%
Cost Of Revenue	$2.414M	$2.113M
YoY Change	14.25%	-21.74%
Gross Profit	$58.87M	$48.83M
YoY Change	20.58%	20.26%
Gross Profit Margin	96.06%	95.85%
Selling, General & Admin	$56.10M	$51.60M
YoY Change	8.72%	42.15%
% of Gross Profit	95.29%	105.68%
Research & Development	$10.77M	$10.47M
YoY Change	2.92%
% of Gross Profit	18.3%	21.44%
Depreciation & Amortization	$1.058M	$999.0K
YoY Change	5.91%	0.91%
% of Gross Profit	1.8%	2.05%
Operating Expenses	$10.77M	$10.47M
YoY Change	2.92%	-71.4%
Operating Profit	-$2.012M	-$3.110M
YoY Change	-35.31%	-178.91%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$14.00K	-$39.00K
YoY Change	-64.1%
Pretax Income	-$2.026M	-$3.149M
YoY Change	-35.66%	-180.74%
Income Tax	$56.00K	-$1.596M
% Of Pretax Income
Net Earnings	-$2.082M	-$1.553M
YoY Change	34.06%	-165.78%
Net Earnings / Revenue	-3.4%	-3.05%
Basic Earnings Per Share	-$0.12	-$0.08
Diluted Earnings Per Share	-$0.12	-$0.08
COMMON SHARES
Basic Shares Outstanding	17.84M shares	18.85M shares
Diluted Shares Outstanding	17.84M shares	18.85M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.40M	$98.20M
YoY Change	-59.88%	-13.56%
Cash & Equivalents	$39.37M	$98.23M
Short-Term Investments
Other Short-Term Assets	$7.500M	$15.70M
YoY Change	-52.23%	33.05%
Inventory
Prepaid Expenses
Receivables	$14.61M	$1.700M
Other Receivables	$13.30M	$6.700M
Total Short-Term Assets	$61.42M	$122.4M
YoY Change	-49.82%	-7.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.944M	$10.40M
YoY Change	-14.0%	46.48%
Goodwill	$14.10M
YoY Change
Intangibles	$10.43M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.875M	$10.40M
YoY Change	-62.74%	-0.95%
Total Long-Term Assets	$37.34M	$46.80M
YoY Change	-20.21%	16.42%
TOTAL ASSETS
Total Short-Term Assets	$61.42M	$122.4M
Total Long-Term Assets	$37.34M	$46.80M
Total Assets	$98.76M	$169.2M
YoY Change	-41.63%	-2.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.303M	$2.400M
YoY Change	-4.04%	-46.67%
Accrued Expenses	$11.20M	$20.30M
YoY Change	-44.83%	89.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$19.15M	$27.20M
YoY Change	-29.61%	47.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$6.700M	$5.900M
YoY Change	13.56%	20.41%
Total Long-Term Liabilities	$6.650M	$5.900M
YoY Change	12.71%	20.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.15M	$27.20M
Total Long-Term Liabilities	$6.650M	$5.900M
Total Liabilities	$25.80M	$33.10M
YoY Change	-22.07%	42.06%
SHAREHOLDERS EQUITY
Retained Earnings	$12.18M
YoY Change
Common Stock	$29.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$200.0M
YoY Change
Treasury Stock Shares
Shareholders Equity	$72.97M	$136.1M
YoY Change
Total Liabilities & Shareholders Equity	$98.76M	$169.2M
YoY Change	-41.63%	-2.2%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$2.082M	-$1.553M
YoY Change	34.06%	-165.78%
Depreciation, Depletion And Amortization	$1.058M	$999.0K
YoY Change	5.91%	0.91%
Cash From Operating Activities	-$11.17M	-$5.410M
YoY Change	106.51%	901.85%
INVESTING ACTIVITIES
Capital Expenditures	$384.0K	$1.115M
YoY Change	-65.56%	-172.4%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$384.0K	-$5.615M
YoY Change	-93.16%	264.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$499.0K	$2.186M
YoY Change	-122.83%	-108.69%
NET CHANGE
Cash From Operating Activities	-$11.17M	-$5.410M
Cash From Investing Activities	-$384.0K	-$5.615M
Cash From Financing Activities	-$499.0K	$2.186M
Net Change In Cash	-$12.06M	-$8.839M
YoY Change	36.38%	-67.55%
FREE CASH FLOW
Cash From Operating Activities	-$11.17M	-$5.410M
Capital Expenditures	$384.0K	$1.115M
Free Cash Flow	-$11.56M	-$6.525M
YoY Change	77.1%	-752.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001333493
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17908942	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	eHealth, Inc.
CY2015Q1	dei	Trading Symbol TradingSymbol	EHTH
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2014Q4	ehth	Accrued Marketing Expenses AccruedMarketingExpenses	8707000	USD
CY2015Q1	ehth	Accrued Marketing Expenses AccruedMarketingExpenses	1551000	USD
CY2014Q4	ehth	Accrued Restructuring Charges AccruedRestructuringCharges	0	USD
CY2015Q1	ehth	Accrued Restructuring Charges AccruedRestructuringCharges	1436000	USD
CY2014Q1	ehth	Amortization Of Book Of Business Consideration AmortizationOfBookOfBusinessConsideration	1574000	USD
CY2015Q1	ehth	Amortization Of Book Of Business Consideration AmortizationOfBookOfBusinessConsideration	1962000	USD
CY2014Q1	ehth	Cash Usedto Net Share Settle Equity Awards CashUsedtoNetShareSettleEquityAwards	3304000	USD
CY2015Q1	ehth	Cash Usedto Net Share Settle Equity Awards CashUsedtoNetShareSettleEquityAwards	480000	USD
CY2014Q1	ehth	Customer Care And Enrollment Expense CustomerCareAndEnrollmentExpense	9713000	USD
CY2015Q1	ehth	Customer Care And Enrollment Expense CustomerCareAndEnrollmentExpense	11861000	USD
CY2014Q1	ehth	Increase Decrease In Accrued Marketing Expenses IncreaseDecreaseInAccruedMarketingExpenses	3181000	USD
CY2015Q1	ehth	Increase Decrease In Accrued Marketing Expenses IncreaseDecreaseInAccruedMarketingExpenses	-7156000	USD
CY2015Q1	ehth	Increase Decreasein Accrued Restructuring Charges IncreaseDecreaseinAccruedRestructuringCharges	1771000	USD
CY2014Q1	ehth	Other Revenue OtherRevenue	5363000	USD
CY2015Q1	ehth	Other Revenue OtherRevenue	3469000	USD
CY2014Q1	ehth	Increase Decrease In Deferred Rent Expense IncreaseDecreaseInDeferredRentExpense	8000	USD
CY2015Q1	ehth	Increase Decrease In Deferred Rent Expense IncreaseDecreaseInDeferredRentExpense	27000	USD
CY2014Q1	ehth	Increase Decreasein Accrued Restructuring Charges IncreaseDecreaseinAccruedRestructuringCharges	0	USD
CY2015Q1	ehth	Restructuring Charges Excluding Stockbased Compensation RestructuringChargesExcludingStockbasedCompensation	4370000	USD
CY2014Q1	ehth	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodGrantDateFairValue	8400000	USD
CY2015Q1	ehth	Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodGrantDateFairValue	1200000	USD
CY2015Q1	ehth	Shares Surrendered To Satisfy Tax Withholding Requirements SharesSurrenderedToSatisfyTaxWithholdingRequirements	327947	shares
CY2014Q1	ehth	Technology And Content Expense TechnologyAndContentExpense	10467000	USD
CY2015Q1	ehth	Technology And Content Expense TechnologyAndContentExpense	10773000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5961000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2303000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8200000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14614000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	179000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	180000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	259007000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	260575000	USD
CY2014Q1	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	3200000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2445000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2031000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	354000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	345000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2677000	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2320000	shares
CY2014Q4	us-gaap	Assets Assets	106664000	USD
CY2015Q1	us-gaap	Assets Assets	98761000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	66475000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	61417000	USD
CY2014Q4	us-gaap	Cash Cash	15793000	USD
CY2015Q1	us-gaap	Cash Cash	14742000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107055000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98228000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51415000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39365000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8827000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12050000	USD
CY2014Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	35622000	USD
CY2015Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	24623000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1537000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2081000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	2113000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	2414000	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	54050000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	63300000	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1608000	USD
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1973000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7973000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	14096000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3658000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3800000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	14096000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3149000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3220000	USD
CY2015Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8294000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	869000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	882000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	386000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	386000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	999000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	1058000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	12000	USD
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	5000	USD
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.507
CY2015Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.028
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8204000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8222000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2026000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1596000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6400000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-382000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-152000	USD
CY2014Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1385000	USD
CY2015Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	226000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1802000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3496000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	736000	USD
CY2014Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	45577000	USD
CY2015Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	57819000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10774000	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10429000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	106664000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	98761000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26737000	USD
CY2014Q1	us-gaap	Revenues Revenues	50940000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2996000	USD
CY2015Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4752000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	19146000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6449000	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6650000	USD
CY2015Q1	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	2	class_action_lawsuit
CY2014Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	23109000	USD
CY2015Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	25451000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2186000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-499000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5615000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-384000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5410000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11172000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-1553000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-2082000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	40189000	USD
CY2015Q1	us-gaap	Noncurrent Assets NoncurrentAssets	37344000	USD
CY2015Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	state
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3110000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2012000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5679000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3875000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14000	USD
CY2015Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	2600000	USD
CY2014Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4500000	USD
CY2015Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1115000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	384000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6474000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7052000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2283000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9640000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8944000	USD
CY2014Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	13000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	19000	USD
CY2014Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	1803000	USD
CY2015Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	1569000	USD
CY2014Q1	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2015Q1	us-gaap	Restructuring Charges RestructuringCharges	4483000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14261000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12179000	USD
CY2014Q4	us-gaap	Restructuring Reserve RestructuringReserve	0.00	USD
CY2015Q1	us-gaap	Restructuring Reserve RestructuringReserve	1770000	USD
CY2015Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1436000	USD
CY2015Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	334000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18849000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17844000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18849000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17844000	shares
CY2015Q1	us-gaap	Revenues Revenues	61288000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2445000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2031000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	19000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	200000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.647
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0113
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4164000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3992000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.69
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y7M2D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	500000	USD
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	600000	USD
CY2014Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	642000	USD
CY2015Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	462000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	73478000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	72965000	USD
CY2014Q4	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	10945607	shares
CY2015Q1	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	10991835	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	199998000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	199998000	USD
CY2015Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Business—</font><font style="font-family:inherit;font-size:10pt;">eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading private online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealth.com</font><font style="font-family:inherit;font-size:10pt;">,  </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealthInsurance.com</font><font style="font-family:inherit;font-size:10pt;">,  </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.eHealthMedicare.com, www.Medicare.com</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.PlanPrescriber.com)</font><font style="font-family:inherit;font-size:10pt;">, consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all </font><font style="font-family:inherit;font-size:10pt;">50</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia. </font></div></div>

Files In Submission

Name	View Source	Status
0001333493-15-000044-index-headers.html	Edgar Link	pending
0001333493-15-000044-index.html	Edgar Link	pending
0001333493-15-000044.txt	Edgar Link	pending
0001333493-15-000044-xbrl.zip	Edgar Link	pending
ehth-20150331.xml	Edgar Link	completed
ehth-20150331.xsd	Edgar Link	pending
ehth-20150331_cal.xml	Edgar Link	unprocessable
ehth-20150331_def.xml	Edgar Link	unprocessable
ehth-20150331_lab.xml	Edgar Link	unprocessable
ehth-20150331_pre.xml	Edgar Link	unprocessable
ehth3311510q.htm	Edgar Link	pending
ehth33115exhibit102.htm	Edgar Link	pending
ehth33115exhibit311.htm	Edgar Link	pending
ehth33115exhibit312.htm	Edgar Link	pending
ehth33115exhibit321.htm	Edgar Link	pending
ehth33115exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EHTH
eHealth, Inc. Stock $ehth

2015 Q1 Form 10-Q Financial Statement

#000133349315000044 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHTH eHealth, Inc. Stock $ehth

2015 Q1 Form 10-Q Financial Statement

#000133349315000044 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHTH
eHealth, Inc. Stock $ehth